user

Linagliptin is an Effective Therapeutic for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH)

被引：0
|
作者：
Klein, Thomas
Mark, Michael
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1035-P
引用
收藏
页码：A265 / A266
页数：2
相关论文
共 50 条
  • [41] LDL:HDL Ratio as a Risk Factor for Non-Alcoholic Steatohepatitis (NASH) in Non-Obese Non-Alcoholic Fatty Liver Disease (NAFLD) Patients
    Mitchell, Brittany
    Aggarwal, Manik
    McCullough, Arthur
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S544 - S545
  • [42] Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Bifari, Francesco
    Manfrini, Roberto
    Cas, Michele Dei
    Berra, Cesare
    Siano, Matteo
    Zuin, Massimo
    Paroni, Rita
    Folli, Franco
    [J]. PHARMACOLOGICAL RESEARCH, 2018, 137 : 219 - 229
  • [43] Impact of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) on the expression and function of hepatobiliary transporters: A comprehensive mechanistic review
    Laddha, Ankit P.
    Dzielak, Lindsey
    Lewis, Cedric
    Xue, Raymond
    Manautou, Jose E.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (03):
  • [44] Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in High-Risk Undiagnosed Adults in South Florida
    Chaudhary, Dhishna
    Sidhu, Simran
    Manam, Rupesh
    Manraj, Kevan
    Lanza, Melaine
    DeDonno, Michael A.
    Baum, Seth J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S495 - S495
  • [45] Non-alcoholic fatty liver disease (NAFLD)
    Rau, Monika
    Weiss, Johannes
    Geier, Andreas
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (14) : 1051 - +
  • [46] Serum adiponectin levels correlate strongly with non-alcoholic steatohepatitis (NASH) grade and fibrosis stage in non-alcoholic fatty liver disease (NAFLD)
    Savvidou, Savvoula
    Goulis, John
    Hytiroglou, Prodromos
    Orfanou-Koumerkeridou, Eleni
    Frantzoulis, Peggy
    Panderis, Athanasia
    Arvanitakis, Constantine
    [J]. HEPATOLOGY, 2006, 44 (04) : 644A - 644A
  • [47] Non-alcoholic fatty liver disease and steatohepatitis
    Par Gabriella
    Horvath Gabor
    Par Alajos
    [J]. ORVOSI HETILAP, 2013, 154 (29) : 1124 - 1134
  • [48] NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS RELATED TO NON-ALCOHOLIC FATTY PANCREAS DISEASE (NAFPD)
    van Geenen, Erwin-Jan M.
    Smits, Mark M.
    Schreuder, Tim C.
    Bloemena, Elisabeth
    van der Peet, Donald L.
    Mulder, Chris J.
    [J]. HEPATOLOGY, 2009, 50 (04) : 788A - 788A
  • [49] Predictors of non-alcoholic steatohepatitis and fibrosis in non-alcoholic fatty liver disease.
    Pong, JP
    Elariny, H
    Younoszai, A
    [J]. HEPATOLOGY, 2002, 36 (04) : 407A - 407A
  • [50] An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Marin, Veronica
    Rosso, Natalia
    Dal Ben, Matteo
    Raseni, Alan
    Boschelle, Manuela
    Degrassi, Cristina
    Nemeckova, Ivana
    Nachtigal, Petr
    Avellini, Claudio
    Tiribelli, Claudio
    Gazzin, Silvia
    [J]. PLOS ONE, 2016, 11 (07):
12345